[Acute ischaemic stroke - Update].

Heldner, Mirjam Rachel; Kaesmacher, Johannes; Mordasini, Pasquale; Fischer, Urs (2018). [Acute ischaemic stroke - Update]. Therapeutische Umschau, 75(7), pp. 411-419. Hogrefe 10.1024/0040-5930/a001017

Full text not available from this repository. (Request a copy)

Acute ischaemic stroke - Update Abstract. Intravenous thrombolysis and / or endovascular therapy are effective and safe in acute ischaemic stroke if patients are selected accordingly. Despite bleeding complications, disability rates may be lowered by treatment. Latest studies investigated intravenous thrombolysis with rt-PA in a treatment window of > 4.5 hours after symptom onset or in case of unknown symptom onset, the application of tenecteplase as thrombolytic agent applied intravenously with and without endovascular therapy, endovascular therapy in a treatment window of > 6 - 24 hours or in case of unknown symptom onset as well as outcome in dependence of general anaesthesia or conscious sedation for endovascular therapy.

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Neurology
04 Faculty of Medicine > Department of Radiology, Neuroradiology and Nuclear Medicine (DRNN) > Institute of Diagnostic and Interventional Neuroradiology

UniBE Contributor:

Heldner, Mirjam Rachel; Kaesmacher, Johannes; Mordasini, Pasquale and Fischer, Urs

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0040-5930

Publisher:

Hogrefe

Language:

German

Submitter:

Martin Zbinden

Date Deposited:

02 Oct 2019 15:51

Last Modified:

02 Oct 2019 15:51

Publisher DOI:

10.1024/0040-5930/a001017

PubMed ID:

30935356

URI:

https://boris.unibe.ch/id/eprint/130071

Actions (login required)

Edit item Edit item
Provide Feedback